The good news is out! Edo State is set to become a major player in Nigeria’s healthcare scene, with plans to kick off local production of essential medicines by 2026. This ambitious move, championed by Governor Monday Okpebholo, aims to slash medical costs, combat medical tourism, and bring much-needed relief to citizens across the state and even the entire South-South region. This initiative is a key part of President Bola Tinubu’s broader ‘Renewed Hope Agenda’ for Nigeria.
- Edo State will start producing essential drugs locally from 2026.
- This aims to reduce the cost of healthcare and curb medical tourism.
- The old Edo Pharmaceutical Company will be revived and modernized.
- Facilities were damaged during the EndSARS protests in 2020.
- The move aligns with the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC).
Edo’s Bold Leap into Pharmaceutical Production
Governor Monday Okpebholo is showing serious commitment to the health and well-being of Edo State’s people. During a recent inspection of the Central Medical Stores, overseen by the Edo State Drugs and Health Commodities Management Agency (DMA), his administration’s readiness to tackle the pharmaceutical sector head-on was evident. The Deputy Governor, Hon. Dennis Idahosa, who represented the governor, made it clear: the dormant Edo Pharmaceutical Company is about to get a serious makeover and return to its former glory.
The primary goal? To put an end to the costly practice of medical tourism, where citizens are forced to seek treatment abroad or in other states due to a lack of local options. The governor understands that readily available and affordable medication is not a luxury, but a necessity. He envisions a future where the people of Edo State, and indeed the entire South-South region, have access to vital drugs without breaking the bank.
Revitalizing a Scarred Legacy
It’s a known fact that the facilities at both the Edo Pharmaceutical Company and the Central Medical Stores suffered significant damage during the EndSARS protests in 2020. However, instead of letting this setback define the future, Governor Okpebholo sees it as an opportunity for a fresh start. The plan is to not just repair, but to upgrade and repurpose these facilities to meet modern production standards. This isn’t just about rebuilding; it’s about building better.
The Power of the Presidential Initiative
This forward-thinking move by Edo State is perfectly in sync with the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC). This nationwide program is designed to supercharge Nigeria’s healthcare system by attracting investment, boosting local manufacturing of medical products, and expanding the role of the private sector. By leveraging PVAC, Edo State is positioning itself as a leader in healthcare innovation and self-sufficiency.
“The governor is passionate about the welfare of the people of Edo State,” remarked Idahosa, highlighting the administration’s hands-on approach. “Hence, he told us to come, look around, and let him know where there are areas of concern and where they need immediate intervention.”
Ensuring Quality and Accessibility
The inspection wasn’t just about future plans; it was also about current provisions. The team meticulously checked the manufacturing and expiration dates of drugs already supplied by the state government, ensuring they are safe and effective for the good people of Edo. This attention to detail underscores the administration’s commitment to providing only the best healthcare services.
Dr. Cyril Oshiomhole, the Commissioner for Health, elaborated on the crucial role of the DMA. He explained that the agency was established with a clear purpose: to ensure affordable and accessible healthcare, a promise made during election campaigns. The DMA’s unique approach involves a pooled procurement system involving all 36 states. This collective bargaining power allows for significant price reductions, often bringing costs below manufacturing prices.
A Win-Win for Everyone
The implications of this initiative are vast. Not only will federal medical centers and even private pharmacies be able to procure drugs from the state, creating a robust local market, but it also promises a ‘win-win’ situation for all stakeholders, particularly the most vulnerable members of society. The planned revival of drug production is slated for the 2026 annual plan, with preparations well underway for the next financial year.
Collaboration for a Healthier Future
The Edo State government is working hand-in-hand with the Federal Government to bring back the production of critical medicines like Panadol, antimalarials, and other essential drugs. This collaborative spirit is key to achieving the goal of a healthier, more self-reliant Nigeria.
About The Author
